Activities per year
Activities
- 1 - 50 out of 62 results
Search results
-
Neurochemistry of DLB and PDD. DLB2006 Yokohama Japan (Invited Speaker)
Francis, P. (Keynote/plenary speaker)
Nov 2006 → …Activity: Participating in or organising an event › Participation in conference
-
Glutamatergic mechanisms in agaitaion/aggression in dementia. National Institute of Neurology and Neurosurgery Mexico City Plenary speaker
Francis, P. (Keynote/plenary speaker)
Oct 2006 → …Activity: Participating in or organising an event › Participation in conference
-
The neurochemical concept of cognitive disorders in PD. “Cognitive dysfunction in Parkinson’s disease a practical approach” University Medical Center Groningen The Netherlands ( Invited speaker)
Francis, P. (Keynote/plenary speaker)
Sept 2006 → …Activity: Participating in or organising an event › Participation in conference
-
Biochemical basis of behavioural disturbance in dementia: implications for therapy. CINP Chicago (Invited speaker)
Francis, P. (Keynote/plenary speaker)
Jul 2006 → …Activity: Participating in or organising an event › Participation in conference
-
Alzheimer's Disease as a Disorder Involving Multiple Physiological Biochemical and Molecular Alterations: What are the Implications for Clinical Course and Therapeutics? 9th Int. Geneva/Springfield Symposium on Advances in AD Therapy Geneva (. Invited speaker.)
Francis, P. (Keynote/plenary speaker)
Apr 2006 → …Activity: Participating in or organising an event › Participation in conference
-
Neurochemical networks in PD. The 4th International Parkinson Disease Symposium in Takamatsu Plenary speaker
Francis, P. (Keynote/plenary speaker)
Mar 2006 → …Activity: Participating in or organising an event › Participation in conference
-
new symptomatic treatment for AD by BTG plc, first meeting Madrid
Francis, P. (Advisor)
2006 → …Activity: Other › Types of Business and Community - Work on advisory panel to industry or government or non-government organisation
-
Eisai, Lisbon,
Francis, P. (Advisor)
2006 → …Activity: Other › Types of Business and Community - Work on advisory panel to industry or government or non-government organisation
-
Glutamatergic neurotransmission in Alzheimer's disease. Wyeth laboratories. Invited speaker
Francis, P. (Keynote/plenary speaker)
Nov 2005 → …Activity: Participating in or organising an event › Participation in conference
-
Neurochemical changes in dementia - new targets for therapy. International College of Geriatric Psychopharmacology, Pittsburgh. Symposium Organiser, Chairman and speaker
Francis, P. (Chair)
Nov 2005 → …Activity: Participating in or organising an event › Participation in conference
-
Therapeutic controversies in Alzheimer's Disease-current and future. Japanese Dementia Society Osaka Plenary speaker
Francis, P. (Keynote/plenary speaker)
Sept 2005 → …Activity: Participating in or organising an event › Participation in conference
-
Cholinergic and other Neurotransmitter Mechanisms in Parkinson's Disease and related disorders. 10th International Symposium on PD Kobe Japan. Invited Speaker
Francis, P. (Keynote/plenary speaker)
Sept 2005 → …Activity: Participating in or organising an event › Participation in conference
-
The Rationale for a Glutamatergic Therapeutic in AD. BPS Summer meeting, Cambridge. Symposium chairman and speaker
Francis, P. (Chair)
Jul 2005 → …Activity: Participating in or organising an event › Participation in conference
-
The Glutamatergic System and its Role in Higher Mental Function and Dysfunction. BAP Summer meeting, Harrogate. Symposium chairman and speaker
Francis, P. (Chair)
Jul 2005 → …Activity: Participating in or organising an event › Participation in conference
-
Glutamatergic mechanisms in Alzheimer’s disease. Turkish National Cognitive Neurology Symposium. Marmaris. Plenary speaker
Francis, P. (Keynote/plenary speaker)
May 2005 → …Activity: Participating in or organising an event › Participation in conference
-
Invited to join advisory board meeting on mechanism of action of memantine at invitation of Merz, Lundbeck and Forest Labs, Frankfurt,
Francis, P. (Advisor)
2005 → …Activity: Other › Types of Business and Community - Work on advisory panel to industry or government or non-government organisation
-
Neurotransmitter imbalance in AD – the role of glutamate. Symposium at ECNP, , Stockholm. Invited speaker. CME accredited
Francis, P. (Keynote/plenary speaker)
Oct 2004 → …Activity: Participating in or organising an event › Participation in conference
-
Disease Modification in AD: New Evidence for Cholinesterase Inhibitors. Symposium at the ICAD Philadelphia, USA, Invited speaker. CME accredited
Francis, P. (Keynote/plenary speaker)
Jul 2004 → …Activity: Participating in or organising an event › Participation in conference
-
Neurotransmitter imbalance in AD – the role of glutamate. Symposium at CINP. , Paris. Invited speaker. CME accredited
Francis, P. (Keynote/plenary speaker)
Jun 2004 → …Activity: Participating in or organising an event › Participation in conference
-
The role of glutamate and the interplay with other neurotransmitter systems. Invited lecture Advances in Alzheimer's Therapy (AAT), Montreal. CME accredited
Francis, P. (Keynote/plenary speaker)
Apr 2004 → …Activity: Participating in or organising an event › Participation in conference
-
Neuroproctective actions of cholinesterase inhibitors Global College of Neuroprotection and Neuroregeneration, Zermatt, Switzerland
Francis, P. (Speaker)
Feb 2004 → …Activity: Participating in or organising an event › Participation in conference
-
Invited to take part in Aricept advisory board at invitation of Pfizer/Eisai, Tokyo,
Francis, P. (Advisor)
2004 → …Activity: Other › Types of Business and Community - Work on advisory panel to industry or government or non-government organisation
-
Glutamatergic-cholinergic interactions: implications for symptomatic treatment of Alzheimer’s disease. Invited Lecture, Wolfson Centre for Ageing and Health, University of Newcastle-Upon-Tyne,
Francis, P. (Invited speaker)
Oct 2003 → …Activity: Participating in or organising an event › Participation in conference
-
Comparing cholinesterase inhibitors. ARICEPT Global Investigators’ meeting at the invitation of Pfizer Inc. Key Biscayne, Fl, USA. Plenary lecture and workshop chairman
Francis, P. (Speaker)
Feb 2003 → …Activity: Participating in or organising an event › Participation in conference
-
Invited to take part in Aricept advisory board at invitation of Pfizer/Eisai, Miami,
Francis, P. (Advisor)
2003 → …Activity: Other › Types of Business and Community - Work on advisory panel to industry or government or non-government organisation
-
Cholinergic systems in Alzheimer’s disease. Master Class in Dementia, St John’s College, Cambridge. . Plenary lecture
Francis, P. (Speaker)
Sept 2002 → …Activity: Participating in or organising an event › Participation in conference
-
The cholinergic hypothesis of Alzheimer’s disease: A review of progress. Invited lecture Johannes-Gutenberg University, Mainz, Germany
Francis, P. (Invited speaker)
Sept 2002 → …Activity: Participating in or organising an event › Participation in conference
-
Mode of action of cholinesterase inhibitors. Canadian ARICEPT Investigator/Consultation Meeting, at the invitation of Pfizer Inc. Québec City, Canada. Plenary lecture
Francis, P. (Speaker)
Sept 2002 → …Activity: Participating in or organising an event › Participation in conference
-
Cholinergic deficits and non-cognitive behavioural changes in patients with Dementia. XIth International Symposium on Cholinergic Mechanisms - Function and Dysfunction and 2nd Misrahi Symposium on Neurobiology. St Moritz, Switzerland. .Invited Speaker, plenary
Francis, P. (Invited speaker)
May 2002 → …Activity: Participating in or organising an event › Participation in conference
-
Transgenic models of Alzheimer’s disease. European Winter Brain Research Conference. Les Arc, France, Invited Speaker, symposium
Francis, P. (Invited speaker)
Mar 2002 → …Activity: Participating in or organising an event › Participation in conference
-
Mechanism of action of cholinesterase inhibitors. Advances in Alzheimer's Therapy (AAT) Geneva, Invited Speaker, symposium. CME accredited
Francis, P. (Invited speaker)
2002 → …Activity: Participating in or organising an event › Participation in conference
-
Biochemical investigation of a transgenic mouse model of Alzheimer's disease. QMW Department of Neuroscience,
Francis, P. (Speaker)
2002 → …Activity: Participating in or organising an event › Participation in conference
-
Reviewer of grant applications for The Wellcome Trust
Francis, P. (Member)
2001 → …Activity: Other › Types of External academic engagement - Membership of peer review panel or committee
-
Consultant to BTG,Plc on novel molecules for AD, on going
Francis, P. (Member)
2001 → …Activity: Other › Types of Business and Community - Work on advisory panel to industry or government or non-government organisation
-
Research into Aging
Francis, P. (Member)
2001 → …Activity: Other › Types of External academic engagement - Membership of peer review panel or committee
-
BBSRC
Francis, P. (Member)
2001 → …Activity: Other › Types of External academic engagement - Membership of peer review panel or committee
-
UK Medical Research Council
Francis, P. (Member)
2001 → …Activity: Other › Types of External academic engagement - Membership of peer review panel or committee
-
AddNeuroMed workflow leader for the InnoMed project funded under FP6 worth Euro12M and involving most of the large Pharma companies operating in Europe and several Biotech companies
Francis, P. (Member)
2001 → …Activity: Other › Types of Business and Community - Work on advisory panel to industry or government or non-government organisation
-
Founder Member International College for Geriatric Psychopharmacology
Francis, P. (Member)
2001 → …Activity: Other › Types of External academic engagement - Membership of external research organisation
-
Acted as a consultant for Pfizer/Eisai at neuroprotection advisory board meetings
Francis, P. (Advisor)
2001 → …Activity: Other › Types of Business and Community - Work on advisory panel to industry or government or non-government organisation
-
Journal of Neurochemistry (Journal)
Francis, P. (Editor)
2001 → …Activity: Publication peer-review and editorial work › Publication peer-review
-
Molecular Psychiatry (Journal)
Francis, P. (Editorial board member)
2001 → 2002Activity: Publication peer-review and editorial work › Editorial activity
-
Reviewer for the British Journal of Psychiatry, British Journal of Pharmacology, Journal of Neurochemistry, Psychopharmacology, TIPS and TINS, Neurology (Journal)
Francis, P. (Editor)
2001 → …Activity: Publication peer-review and editorial work › Publication peer-review
-
British Journal of Pharmacology (Journal)
Francis, P. (Editor)
2001 → …Activity: Publication peer-review and editorial work › Publication peer-review
-
Psychopharmacology (Journal)
Francis, P. (Editor)
2001 → …Activity: Publication peer-review and editorial work › Publication peer-review
-
Reviewer for the British Journal of Psychiatry, British Journal of Pharmacology, Journal of Neurochemistry, Psychopharmacology, TIPS and TINS, Neurology (Journal)
Francis, P. (Editorial board member)
2001 → …Activity: Publication peer-review and editorial work › Editorial activity
-
Motor Neurone Disease Association
Francis, P. (Member)
2001 → …Activity: Other › Types of External academic engagement - Membership of peer review panel or committee
-
British Journal of Psychiatry (Journal)
Francis, P. (Editor)
2001 → …Activity: Publication peer-review and editorial work › Publication peer-review
-
Experimental Neurology (Journal)
Francis, P. (Editorial board member)
2001 → 2002Activity: Publication peer-review and editorial work › Editorial activity
-
Catalan Agency for Health Technology Assessment and Research
Francis, P. (Member)
2001 → …Activity: Other › Types of External academic engagement - Membership of peer review panel or committee